"Stress for success”: Unlocking Venetoclax sensitivity in T-ALL through the mTORC1–ISR–BMF axis. by Prof. Vincenzo Ciminale, MD, Istituto Oncologico Veneto, Padova, Italy When: Thursday, 13.11.2025, 14.30–15.30 Where: Aud. 4, BBB Host: Bjørn Tore Gjertsen Abstract Refractory/relapsed T-cell acute lymphoblastic leukemia (R/R T-ALL) remains a major therapeutic challenge at present. Our recent studies showed that inhibition of mTORC1 markedly sensitizes LES MER
35 hendelser found.
Calendar of Hendelser
|
mandag
|
tirsdag
|
onsdag
|
torsdag
|
fredag
|
lørdag
|
søndag
|
|---|---|---|---|---|---|---|
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
1 hendelse,
-
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
|
0 hendelser,
|
1 hendelse,
-
Tara Helén Steinsland Dowling is presenting and defending for ph.d.-degree with her thesis "Acute myeloid leukemia at single-cell resolution: Clonal heterogeneity in precision therapy" Trial lecture: "Relevance of clonal hematopoiesis in hematological malignancies" Time: 10.15–11.00 Place: HUS - BB-bygget, Auditorium 2 Defense Time: 12.15–15.00 Location: HUS - BB-bygget, Auditorium 2 For more information: https://www.uib.no/nye-doktorgrader/180253/krigen-mellom-klonane-det-klonale-landskapet-i-aml |
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
0 hendelser,
|
